
Biochemistry, food science, test kit development, analytical chemistry
Our core business is to create new IPR in the field of vitamin K, cardiovascular disease and bone health. Patents are licensed out to other parties and together with contract research the royalties form the main income of VitaK. Profits are re-invested in new projects. We have up-to-date facilities for biochemical research and clinical studies. Personnel is of PhD (4) and MSc (HBO) level (8). We have research contracts and business relations with 8 different companies and 12 universities worldwide.